Outcome
    Moderate Evidence

    Vitex (Chasteberry) for Mood Stabilization

    Premenstrual mood symptoms improve, but vitex is not a treatment for mood disorders.

    Overview

    Premenstrual mood symptoms improve, but vitex is not a treatment for mood disorders.

    Verdict

    Mixed evidence

    How It Works

    Reduced prolactin and stabilised luteal hormone profile appear to mitigate cyclical irritability and dysphoria.

    Dosing & Protocol

    Typical dose

    Recommended dose
    20-40 mg/day of standardised extract; benefit is for premenstrual mood symptoms, not mood stabilisation
    Expected timeframe
    3 cycles

    Protocol

    form
    Standardised Vitex agnus-castus fruit extract taken continuously across the cycle
    duration
    3 consecutive cycles before judging
    co factor
    Take once daily in the morning, every day. Evidence is mixed and applies narrowly. Vitex reduces prolactin through pituitary dopamine D2 agonism, and the best evidence is in premenstrual syndrome, where Schellenberg found significant reductions against placebo in irritability, mood alteration, anger, headache and breast fullness over three cycles. Some trials in premenstrual dysphoric disorder found it inferior to fluoxetine for psychological symptoms while better for physical ones. This is cyclical premenstrual mood relief - it is not mood stabilisation in the psychiatric sense of preventing manic and depressive episodes, which vitex has never been tested for.
    titration
    Up to 40 mg/day of extract after 6-8 weeks if the response is partial
    starting dose
    20 mg/day of standardised vitex extract in the morning on an empty stomach

    Evidence

    What the studies say

    Randomised trials report significant reductions in premenstrual irritability and depressed mood, including one trial comparable to fluoxetine for physical symptoms. Non-cyclical depression has not been studied.

    No studies are yet linked to both Vitex (Chasteberry) and Mood Stabilization.

    Safety

    Caveats

    The distinction matters: vitex has reasonable evidence for premenstrual mood symptoms and none at all for mood stabilisation in bipolar disorder, where lithium, valproate, lamotrigine and quetiapine are the treatments that prevent episodes and must not be replaced by a supplement. Charting mood daily for three cycles is the way to tell whether symptoms are genuinely premenstrual or continuous - continuous low mood is depression and responds to therapy and antidepressants, while premenstrual dysphoric disorder responds well to SSRIs, which can be taken luteal-phase only. Thoughts of self-harm need urgent help. Safety of vitex: it is contraindicated in pregnancy and breastfeeding, and should be avoided by anyone with hormone-sensitive cancer including breast cancer. Its dopaminergic action means potential interaction with dopamine agonists such as bromocriptine and cabergoline, and opposition with antipsychotics and metoclopramide - which matters particularly for anyone taking psychiatric medication. It may reduce hormonal contraceptive reliability. Side effects include headache, nausea, acne and menstrual changes.

    Less likely to help if

    Women whose low mood is continuous rather than cyclical, and anyone with bipolar disorder.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.